ANGIODYNAMICS
ANGO Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-01-16
2025-01-17
NIGHAN WARREN JR
SVP Quality and Regulatory
S - Sale
Common Stock
-4,060
$12.00
-48,720
1
$412.16M
2024-12-02
2024-12-04
WEISS LAWRENCE
SVP, Chief Legal Officer
A - Grant
Non-Qualified Stock Option (right to buy)
104K
$0.00
1
$412.16M
2024-12-02
2024-12-04
WEISS LAWRENCE
SVP, Chief Legal Officer
A - Grant
Common Stock
52,697
$0.00
1
$412.16M
2024-10-10
2024-10-10
NIGHAN WARREN JR
SVP Quality and Regulatory
P - Purchase
Common Stock
100
$6.00
600
1
$412.16M
2024-10-07
2024-10-10
NIGHAN WARREN JR
SVP Quality and Regulatory
P - Purchase
Common Stock
768
$6.00
4,608
1
$412.16M
2024-10-08
2024-10-08
TROWBRIDGE STEPHEN
EVP and CFO
P - Purchase
Common Stock
1,700
$6.00
10,200
1
$412.16M
2024-10-07
2024-10-08
CLEMMER JAMES
President and CEO
P - Purchase
Common Stock
20,000
$6.00
120K
1
$412.16M
2024-07-17
2024-08-02
CLEMMER JAMES
President and CEO
M - Exercise
Performance Right
52,378
$0.00
1
$412.16M
2024-07-17
2024-08-02
NIGHAN WARREN JR
SVP Quality and Regulatory
M - Exercise
Performance Right
7,550
$0.00
1
$412.16M
2024-07-17
2024-08-02
NIGHAN WARREN JR
SVP Quality and Regulatory
M - Exercise
Common Stock
5,677
$0.00
1
$412.16M
2024-07-17
2024-08-02
PICCININI LAURA
SVP International
M - Exercise
Performance Right
5,903
$0.00
1
$412.16M
2024-07-17
2024-08-02
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Performance Right
14,817
$0.00
1
$412.16M
2024-07-17
2024-08-02
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-2,379
$7.00
-16,653
1
$412.16M
2024-07-17
2024-08-02
NIGHAN WARREN JR
SVP Quality and Regulatory
F - Tax
Common Stock
-1,666
$7.00
-11,662
1
$412.16M
2024-07-17
2024-08-02
PICCININI LAURA
SVP International
F - Tax
Common Stock
-2,485
$7.00
-17,395
1
$412.16M
2024-07-17
2024-08-02
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Performance Right
8,777
$0.00
1
$412.16M
2024-07-17
2024-08-02
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Common Stock
6,600
$0.00
1
$412.16M
2024-07-21
2024-07-25
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-395
$7.00
-2,765
1
$412.16M
2024-07-21
2024-07-25
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-3,372
$7.00
-23,604
1
$412.16M
2024-07-21
2024-07-25
NIGHAN WARREN JR
SVP Quality and Regulatory
F - Tax
Common Stock
-277
$7.00
-1,939
1
$412.16M
2024-07-20
2024-07-25
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-359
$7.00
-2,513
1
$412.16M
2024-07-20
2024-07-25
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-2,982
$7.00
-20,874
1
$412.16M
2024-07-20
2024-07-25
NIGHAN WARREN JR
SVP Quality and Regulatory
F - Tax
Common Stock
-251
$7.00
-1,757
1
$412.16M
2024-07-19
2024-07-23
PICCININI LAURA
SVP International
F - Tax
Common Stock
-1,983
$7.00
-13,881
1
$412.16M
2024-07-19
2024-07-23
CLEMMER JAMES
President and CEO
A - Grant
Non-Qualified Stock Option (right to buy)
7,466
$0.00
1
$412.16M
2024-07-19
2024-07-23
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-1,025
$7.00
-7,175
1
$412.16M
2024-07-19
2024-07-23
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-8,307
$7.00
-58,149
1
$412.16M
2024-07-19
2024-07-23
NIGHAN WARREN JR
SVP Quality and Regulatory
F - Tax
Common Stock
-735
$7.00
-5,145
1
$412.16M
2024-07-17
2024-07-19
NIGHAN WARREN JR
SVP Quality and Regulatory
A - Grant
Non-Qualified Stock Option (right to buy)
23,507
$0.00
1
$412.16M
2024-07-17
2024-07-19
NIGHAN WARREN JR
SVP Quality and Regulatory
A - Grant
Common Stock
18,733
$0.00
1
$412.16M
2024-07-17
2024-07-19
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Non-Qualified Stock Option (right to buy)
24,240
$0.00
1
$412.16M
2024-07-17
2024-07-19
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Performance Right
24,699
$0.00
1
$412.16M
2024-07-17
2024-07-19
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Common Stock
12,350
$0.00
1
$412.16M
2024-07-17
2024-07-19
NIGHAN WARREN JR
SVP Quality and Regulatory
A - Grant
Performance Right
23,952
$0.00
1
$412.16M
2024-07-17
2024-07-19
PICCININI LAURA
SVP International
A - Grant
Non-Qualified Stock Option (right to buy)
29,863
$0.00
1
$412.16M
2024-07-17
2024-07-19
PICCININI LAURA
SVP International
A - Grant
Performance Right
30,428
$0.00
1
$412.16M
2024-07-17
2024-07-19
TROWBRIDGE STEPHEN
EVP and CFO
A - Grant
Non-Qualified Stock Option (right to buy)
76,458
$0.00
1
$412.16M
2023-07-19
2024-07-19
CLEMMER JAMES
President and CEO
A - Grant
Non-Qualified Stock Option (right to buy)
208K
$0.00
1
$412.16M
2024-04-08
2024-04-08
CLEMMER JAMES
President and CEO
P - Purchase
Common Stock
10,000
$7.00
70,000
1
$412.16M
2023-07-19
2023-09-21
CLEMMER JAMES
President and CEO
M - Exercise
Performance Right
-109K
$0.00
1
$412.16M
2023-07-19
2023-09-21
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Performance Right
-15,081
$0.00
1
$412.16M
2023-07-19
2023-09-21
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Common Stock
9,650
$0.00
1
$412.16M
2023-07-19
2023-09-21
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Performance Right
-30,242
$0.00
1
$412.16M
2023-07-19
2023-09-21
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-3,103
$9.00
-27,927
1
$412.16M
2023-07-19
2023-09-21
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-3,477
$9.00
-31,293
1
$412.16M
2023-07-19
2023-09-21
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Performance Right
-13,453
$0.00
1
$412.16M
2023-07-19
2023-09-21
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Common Stock
8,610
$0.00
1
$412.16M
2023-07-19
2023-07-26
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Performance Right
-15,081
$0.00
1
$412.16M
2023-07-19
2023-07-26
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-1,404
$9.00
-12,636
1
$412.16M
2023-07-19
2023-07-26
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-1,575
$9.00
-14,175
1
$412.16M
2023-07-19
2023-07-26
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Performance Right
-13,453
$0.00
1
$412.16M
2023-07-19
2023-07-26
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Common Stock
3,900
$0.00
1
$412.16M
2023-07-19
2023-07-26
CLEMMER JAMES
President and CEO
M - Exercise
Performance Right
-109K
$0.00
1
$412.16M
2023-07-19
2023-07-26
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Common Stock
4,371
$0.00
1
$412.16M
2023-07-19
2023-07-26
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Performance Right
-30,242
$0.00
1
$412.16M
2023-07-21
2023-07-25
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-395
$9.00
-3,555
1
$412.16M
2023-07-21
2023-07-25
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-3,372
$9.00
-30,348
1
$412.16M
2023-07-21
2023-07-25
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-365
$9.00
-3,285
1
$412.16M
2023-07-20
2023-07-25
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-359
$9.00
-3,231
1
$412.16M
2023-07-20
2023-07-25
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-2,982
$9.00
-26,838
1
$412.16M
2023-07-20
2023-07-25
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-332
$9.00
-2,988
1
$412.16M
2023-07-19
2023-07-21
CLEMMER JAMES
President and CEO
A - Grant
Non-Qualified Stock Option (right to buy)
191K
$0.00
1
$412.16M
2023-07-19
2023-07-21
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Non-Qualified Stock Option (right to buy)
23,561
$0.00
1
$412.16M
2023-07-19
2023-07-21
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Performance Right
22,768
$0.00
1
$412.16M
2023-07-19
2023-07-21
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Common Stock
11,384
$0.00
1
$412.16M
2023-07-19
2023-07-21
CENTEA SCOTT
SVP/GM, VIT
A - Grant
Non-Qualified Stock Option (right to buy)
21,913
$0.00
1
$412.16M
2023-07-19
2023-07-21
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Non-Qualified Stock Option (right to buy)
22,329
$0.00
1
$412.16M
2023-07-19
2023-07-21
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Performance Right
21,578
$0.00
1
$412.16M
2023-07-19
2023-07-21
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Common Stock
10,789
$0.00
1
$412.16M
2023-07-19
2023-07-21
PICCININI LAURA
SVP International
A - Grant
Non-Qualified Stock Option (right to buy)
29,322
$0.00
1
$412.16M
2023-07-19
2023-07-21
PICCININI LAURA
SVP International
A - Grant
Performance Right
28,336
$0.00
1
$412.16M
2023-07-19
2023-07-21
TROWBRIDGE STEPHEN
EVP and CFO
A - Grant
Non-Qualified Stock Option (right to buy)
59,378
$0.00
1
$412.16M
2023-07-17
2023-07-18
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-279
$10.00
-2,790
1
$412.16M
2023-07-17
2023-07-18
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-2,262
$10.00
-22,620
1
$412.16M
2023-07-17
2023-07-18
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-313
$10.00
-3,130
1
$412.16M
2023-07-14
2023-07-18
TROWBRIDGE STEPHEN
EVP and CFO
F - Tax
Common Stock
-1,362
$10.00
-13,620
1
$412.16M
2023-07-14
2023-07-18
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-596
$10.00
-5,960
1
$412.16M
2023-07-14
2023-07-18
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-4,906
$10.00
-49,060
1
$412.16M
2023-07-14
2023-07-18
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-679
$10.00
-6,790
1
$412.16M
2023-06-01
2023-06-02
PICCININI LAURA
SVP International
F - Tax
Common Stock
-1,400
$10.00
-14,000
1
$412.16M
2023-02-01
2023-02-07
ROSENZWEIG RICHARD
SVP and General Counsel
F - Tax
Common Stock
-1,137
$13.00
-14,781
1
$412.16M
2023-01-31
2023-02-01
HELSEL DAVE
SVP Global Operations and R&D
S - Sale
Common Stock
-4,633
$13.00
-60,229
1
$412.16M
2022-10-12
2022-10-12
TROWBRIDGE STEPHEN
EVP and CFO
P - Purchase
Common Stock
1,083
$14.00
15,162
1
$412.16M
2022-10-10
2022-10-11
CLEMMER JAMES
President and CEO
P - Purchase
Common Stock
10,000
$15.00
150K
1
$412.16M
2022-07-29
2022-08-01
HELSEL DAVE
SVP Global Operations and R&D
S - Sale
Common Stock
-5,000
$22.00
-110K
1
$412.16M
2022-07-20
2022-07-22
CENTEA SCOTT
SVP/GM, VIT
A - Grant
Non- Qualified Stock Option (right to buy)
8,680
$0.00
1
$412.16M
2022-07-20
2022-07-22
CLEMMER JAMES
President and CEO
A - Grant
Non- Qualified Stock Option (right to buy)
77,530
$0.00
1
$412.16M
2022-07-20
2022-07-22
CLEMMER JAMES
President and CEO
A - Grant
Performance Right
66,187
$0.00
1
$412.16M
2022-07-20
2022-07-22
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Non-Qualified Stock Option (right to buy)
8,646
$0.00
1
$412.16M
2022-07-20
2022-07-22
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Performance Right
7,381
$0.00
1
$412.16M
2022-07-20
2022-07-22
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Common Stock
3,691
$0.00
1
$412.16M
2022-07-20
2022-07-22
NIGHAN WARREN JR
SVP Quality and Regulatory
A - Grant
Non- Qualified Stock Option (right to buy)
8,027
$0.00
1
$412.16M
2022-07-20
2022-07-22
NIGHAN WARREN JR
SVP Quality and Regulatory
A - Grant
Performance Right
6,852
$0.00
1
$412.16M
2022-07-20
2022-07-22
NIGHAN WARREN JR
SVP Quality and Regulatory
A - Grant
Common Stock
3,426
$0.00
1
$412.16M
2022-07-20
2022-07-22
PICCININI LAURA
SVP International
A - Grant
Non- Qualified Stock Option (right to buy)
10,312
$0.00
1
$412.16M
2022-07-20
2022-07-22
PICCININI LAURA
SVP International
A - Grant
Performance Right
8,803
$0.00
1
$412.16M
2022-07-20
2022-07-22
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Non- Qualified Stock Option (right to buy)
9,283
$0.00
1
$412.16M
2022-07-20
2022-07-22
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Performance Right
7,925
$0.00
1
$412.16M
2022-07-20
2022-07-22
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Common Stock
3,963
$0.00
1
$412.16M
2022-07-20
2022-07-22
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Non- Qualified Stock Option (right to buy)
9,341
$0.00
1
$412.16M
2022-07-20
2022-07-22
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Performance Right
7,974
$0.00
1
$412.16M
2022-07-20
2022-07-22
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Common Stock
3,987
$0.00
1
$412.16M
2022-07-20
2022-07-22
TROWBRIDGE STEPHEN
EVP and CFO
A - Grant
Non-Qualified Stock Option (right to buy)
18,650
$0.00
1
$412.16M
2022-07-15
2022-07-18
JOHNSON WESLEY
M - Exercise
Non- Qualified Stock Option (right to buy)
-6,022
$0.00
1
$412.16M
2022-07-15
2022-07-18
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Non- Qualified Stock Option (right to buy)
-14,758
$0.00
1
$412.16M
2022-07-15
2022-07-18
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Common Stock
14,758
$16.00
236K
1
$412.16M
2022-07-12
2022-07-14
METENY DENNIS
M - Exercise
Non-Qualified Stock Option (right to buy)
-6,022
$0.00
1
$412.16M
2022-07-07
2022-07-11
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-1,078
$21.00
-22,638
1
$412.16M
2022-07-07
2022-07-11
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-1,223
$21.00
-25,683
1
$412.16M
2022-07-07
2022-07-11
NIGHAN WARREN JR
SVP Quality and Regulatory
F - Tax
Common Stock
-919
$21.00
-19,299
1
$412.16M
2022-07-07
2022-07-11
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Common Stock
3,480
$0.00
1
$412.16M
2022-07-07
2022-07-11
NIGHAN WARREN JR
SVP Quality and Regulatory
M - Exercise
Performance Right
-6,452
$0.00
1
$412.16M
2022-07-07
2022-07-11
NIGHAN WARREN JR
SVP Quality and Regulatory
M - Exercise
Common Stock
3,233
$0.00
1
$412.16M
2022-07-07
2022-07-11
TROWBRIDGE STEPHEN
EVP and CFO
F - Tax
Common Stock
-1,509
$21.00
-31,689
1
$412.16M
2022-07-07
2022-07-11
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Performance Right
-6,195
$0.00
1
$412.16M
2022-07-07
2022-07-11
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Common Stock
3,104
$0.00
1
$412.16M
2022-07-07
2022-07-11
CLEMMER JAMES
President and CEO
M - Exercise
Performance Right
-50,139
$0.00
1
$412.16M
2022-07-07
2022-07-11
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Performance Right
-6,945
$0.00
1
$412.16M
2022-07-07
2022-07-11
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Performance Right
-8,357
$0.00
1
$412.16M
2022-04-28
2022-05-02
HELSEL DAVE
SVP Global Operations and R&D
S - Sale
Common Stock
-3,513
$22.00
-77,286
1
$412.16M
2022-04-20
2022-04-21
DONNELLY HOWARD
M - Exercise
Non-Qualified Stock Option (right to buy)
-6,022
$0.00
1
$412.16M
2022-02-01
2022-02-03
ROSENZWEIG RICHARD
SVP and General Counsel
F - Tax
Common Stock
-1,194
$21.00
-25,074
1
$412.16M
2022-01-12
2022-01-12
TROWBRIDGE STEPHEN
EVP and CFO
P - Purchase
Common Stock
1,000
$23.00
23,000
1
$412.16M
2022-01-11
2022-01-12
CLEMMER JAMES
President and CEO
P - Purchase
Common Stock
10,000
$23.00
230K
1
$412.16M
2021-07-21
2021-12-30
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Non-Qualified Stock Option (right to buy)
11,026
$0.00
1
$412.16M
2021-07-21
2021-12-30
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Non-Qualified Stock Option (right to buy)
8,418
$0.00
1
$412.16M
2021-07-21
2021-12-30
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Peformance Right
6,197
$0.00
1
$412.16M
2021-07-21
2021-12-30
TROWBRIDGE STEPHEN
EVP and CFO
A - Grant
Non-Qualified Stock Option (right to buy)
20,128
$0.00
1
$412.16M
2021-07-21
2021-12-30
CLEMMER JAMES
President and CEO
A - Grant
Non-Qualified Stock Option (right to buy)
102K
$0.00
1
$412.16M
2021-07-21
2021-12-30
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Non-Qualified Stock Option (right to buy)
11,923
$0.00
1
$412.16M
2021-07-21
2021-12-30
CENTEA SCOTT
SVP/GM, VIT
A - Grant
Non-Qualified Stock Option (right to buy)
7,721
$0.00
1
$412.16M
2021-07-21
2021-12-30
CLEMMER JAMES
President and CEO
A - Grant
Performance Right
74,840
$0.00
1
$412.16M
2021-10-31
2021-11-05
CENTEA SCOTT
Sr. VP/GM, Global VIT
F - Tax
Common Stock
-953
$29.00
-27,637
1
$412.16M
2021-10-20
2021-10-21
HELSEL DAVE
SVP Global Operations and R&D
S - Sale
Common Stock
-3,494
$28.00
-97,832
1
$412.16M
2021-07-21
2021-10-21
PICCININI LAURA
SVP International
A - Grant
Non-Qualified Stock Option (right to buy)
8,019
$0.00
1
$412.16M
2021-07-21
2021-10-21
PICCININI LAURA
SVP International
A - Grant
Performance Right
5,903
$0.00
1
$412.16M
2021-10-15
2021-10-18
CENTEA SCOTT
Sr. VP/GM, Global VIT
M - Exercise
Non-Qualified Stock Option (right to buy)
-12,000
$0.00
1
$412.16M
2021-10-15
2021-10-18
CENTEA SCOTT
Sr. VP/GM, Global VIT
S - Sale
Common Stock
-12,000
$28.00
-336K
1
$412.16M
2021-10-15
2021-10-18
CENTEA SCOTT
Sr. VP/GM, Global VIT
M - Exercise
Common Stock
12,000
$17.00
204K
1
$412.16M
2021-10-05
2021-10-06
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
S - Sale
Common Stock
-10,748
$27.00
-290K
1
$412.16M
2021-10-05
2021-10-06
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Non-Qualified Stock Option (right to buy)
-10,748
$0.00
1
$412.16M
2021-10-05
2021-10-06
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Common Stock
10,748
$17.00
183K
1
$412.16M
2021-08-12
2021-08-18
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-3,130
$27.00
-84,510
1
$412.16M
2021-08-12
2021-08-18
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-21,532
$27.00
-581K
1
$412.16M
2021-08-12
2021-08-18
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-3,347
$27.00
-90,369
1
$412.16M
2021-08-12
2021-08-18
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Performance Right
-7,079
$0.00
1
$412.16M
2021-08-12
2021-08-18
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Common Stock
8,210
$0.00
1
$412.16M
2021-08-12
2021-08-18
CLEMMER JAMES
President and CEO
M - Exercise
Performance Right
-34,938
$0.00
1
$412.16M
2021-08-12
2021-08-18
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Performance Right
-9,834
$0.00
1
$412.16M
2021-08-12
2021-08-18
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Common Stock
11,406
$0.00
1
$412.16M
2021-08-12
2021-08-18
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Performance Right
-9,437
$0.00
1
$412.16M
2021-08-12
2021-08-17
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-702
$27.00
-18,954
1
$412.16M
2021-08-12
2021-08-17
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-788
$27.00
-21,276
1
$412.16M
2021-08-12
2021-08-17
TROWBRIDGE STEPHEN
EVP and CFO
F - Tax
Common Stock
-1,231
$27.00
-33,237
1
$412.16M
2021-08-12
2021-08-17
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Performance Right
-6,195
$0.00
1
$412.16M
2021-08-12
2021-08-17
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
M - Exercise
Common Stock
2,395
$0.00
1
$412.16M
2021-08-12
2021-08-17
CLEMMER JAMES
President and CEO
M - Exercise
Performance Right
-50,139
$0.00
1
$412.16M
2021-08-12
2021-08-17
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Performance Right
-6,945
$0.00
1
$412.16M
2021-08-12
2021-08-17
HELSEL DAVE
SVP Global Operations and R&D
M - Exercise
Common Stock
2,685
$0.00
1
$412.16M
2021-08-12
2021-08-17
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Performance Right
-8,357
$0.00
1
$412.16M
2021-07-28
2021-07-30
JOHNSON WESLEY
M - Exercise
Non-Qualified Stock Option (right to buy)
-5,726
$0.00
1
$412.16M
2021-07-28
2021-07-30
METENY DENNIS
M - Exercise
Non-Qualified Stock Option (right to buy)
-5,726
$0.00
1
$412.16M
2021-07-26
2021-07-27
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-318
$26.00
-8,268
1
$412.16M
2021-07-26
2021-07-27
CENTEA SCOTT
Sr. VP/GM, Global VIT
F - Tax
Common Stock
-419
$26.00
-10,894
1
$412.16M
2021-07-26
2021-07-27
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-2,105
$26.00
-54,730
1
$412.16M
2021-07-21
2021-07-23
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Non-Qualified Stock Option (right to buy)
11,923
$0.00
1
$412.16M
2021-07-21
2021-07-23
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Performance Right
8,777
$0.00
1
$412.16M
2021-07-21
2021-07-23
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Common Stock
4,388
$0.00
1
$412.16M
2021-07-21
2021-07-23
CENTEA SCOTT
SVP/GM, VIT
A - Grant
Non-Qualified Stock Option (right to buy)
7,721
$0.00
1
$412.16M
2021-07-21
2021-07-23
CLEMMER JAMES
President and CEO
A - Grant
Non-Qualified Stock Option (right to buy)
71,154
$0.00
1
$412.16M
2021-07-21
2021-07-23
CLEMMER JAMES
President and CEO
A - Grant
Performance Right
52,378
$0.00
1
$412.16M
2021-07-21
2021-07-23
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Non-Qualified Stock Option (right to buy)
11,026
$0.00
1
$412.16M
2021-07-21
2021-07-23
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Performance Right
8,116
$0.00
1
$412.16M
2021-07-21
2021-07-23
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Common Stock
4,058
$0.00
1
$412.16M
2021-07-21
2021-07-23
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Non-Qualified Stock Option (right to buy)
8,418
$0.00
1
$412.16M
2021-07-21
2021-07-23
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Performance Right
6,197
$0.00
1
$412.16M
2021-07-21
2021-07-23
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Common Stock
3,098
$0.00
1
$412.16M
2021-07-21
2021-07-23
TROWBRIDGE STEPHEN
EVP and CFO
A - Grant
Non-Qualified Stock Option (right to buy)
20,128
$0.00
1
$412.16M
2021-07-18
2021-07-23
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-1,483
$25.00
-37,075
1
$412.16M
2021-07-18
2021-07-23
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-300
$25.00
-7,500
1
$412.16M
2021-07-18
2021-07-23
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-417
$25.00
-10,425
1
$412.16M
2021-07-17
2021-07-23
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-262
$25.00
-6,550
1
$412.16M
2021-07-17
2021-07-23
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-294
$25.00
-7,350
1
$412.16M
2021-07-17
2021-07-23
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-2,131
$25.00
-53,275
1
$412.16M
2021-07-14
2021-07-23
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-571
$26.00
-14,846
1
$412.16M
2021-07-14
2021-07-23
TROWBRIDGE STEPHEN
EVP and CFO
F - Tax
Common Stock
-1,284
$26.00
-33,384
1
$412.16M
2021-07-14
2021-07-23
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-640
$26.00
-16,640
1
$412.16M
2021-04-15
2021-04-16
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Non-Qualified Stock Option (right to buy)
-13,625
$0.00
1
$412.16M
2021-04-15
2021-04-16
TROWBRIDGE STEPHEN
EVP and CFO
M - Exercise
Common Stock
13,625
$14.00
191K
1
$412.16M
2021-04-14
2021-04-15
HELSEL DAVE
SVP Global Operations and R&D
S - Sale
Common Stock
-3,500
$24.00
-84,000
1
$412.16M
2021-04-01
2021-04-05
DONNELLY HOWARD
M - Exercise
Non-Qualified Stock Option (right to buy)
-5,726
$0.00
1
$412.16M
2021-02-01
2021-02-03
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Non-Qualified Stock Option (right to buy)
62,000
$0.00
1
$412.16M
2021-02-01
2021-02-03
ROSENZWEIG RICHARD
SVP and General Counsel
A - Grant
Common Stock
11,000
$0.00
1
$412.16M
2020-12-18
2020-12-21
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-733
$14.00
-10,262
1
$412.16M
2020-08-11
2020-08-12
TROWBRIDGE STEPHEN
EVP and CFO
P - Purchase
Common Stock
1,013
$9.00
9,117
1
$412.16M
2020-07-31
2020-08-03
CLEMMER JAMES
President and CEO
P - Purchase
Common Stock
40,000
$8.00
320K
1
$412.16M
2020-07-27
2020-07-28
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-259
$9.00
-2,331
1
$412.16M
2020-07-27
2020-07-28
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-1,799
$9.00
-16,191
1
$412.16M
2020-07-26
2020-07-28
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-283
$9.00
-2,547
1
$412.16M
2020-07-26
2020-07-28
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-1,876
$9.00
-16,884
1
$412.16M
2020-07-18
2020-07-21
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-300
$9.00
-2,700
2
$412.16M
2020-07-18
2020-07-21
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-1,483
$9.00
-13,347
1
$412.16M
2020-07-18
2020-07-21
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-362
$9.00
-3,258
2
$412.16M
2020-07-17
2020-07-21
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-254
$9.00
-2,286
1
$412.16M
2020-07-17
2020-07-21
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-262
$9.00
-2,358
1
$412.16M
2020-07-17
2020-07-21
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-2,131
$9.00
-19,179
1
$412.16M
2020-07-14
2020-07-17
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Non-Qualified Stock Option (right to buy)
19,800
$0.00
1
$412.16M
2020-07-14
2020-07-17
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Performance Right
13,453
$0.00
1
$412.16M
2020-07-14
2020-07-17
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
A - Grant
Common Stock
6,726
$0.00
1
$412.16M
2020-07-14
2020-07-17
CLEMMER JAMES
President and CEO
A - Grant
Non-Qualified Stock Option (right to buy)
160K
$0.00
1
$412.16M
2020-07-14
2020-07-17
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Non-Qualified Stock Option (right to buy)
22,196
$0.00
1
$412.16M
2020-07-14
2020-07-17
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Performance Right
15,081
$0.00
1
$412.16M
2020-07-14
2020-07-17
HELSEL DAVE
SVP Global Operations and R&D
A - Grant
Common Stock
7,540
$0.00
1
$412.16M
2020-07-14
2020-07-17
TROWBRIDGE STEPHEN
EVP and CFO
A - Grant
Non-Qualified Stock Option (right to buy)
44,510
$0.00
1
$412.16M
2020-05-23
2020-05-27
CAMPBELL CHAD THOMAS
SVP/GM, Vascular Access
F - Tax
Common Stock
-826
$11.00
-9,086
1
$412.16M
2020-04-04
2020-04-07
CLEMMER JAMES
President and CEO
F - Tax
Common Stock
-4,245
$10.00
-42,450
1
$412.16M
2020-02-12
2020-02-18
BOUCHER BRENT
SVP and GM of Oncology
F - Tax
Common Stock
-490
$13.00
-6,370
1
$412.16M
2020-02-03
2020-02-07
TROWBRIDGE STEPHEN
EVP, General Counsel and CFO
A - Grant
Common Stock
5,376
$0.00
1
$412.16M
2020-02-03
2020-02-07
TROWBRIDGE STEPHEN
EVP, General Counsel and CFO
A - Grant
Non-Qualified Stock Option (right to buy)
18,204
$0.00
1
$412.16M
2020-01-17
2020-01-21
BOUCHER BRENT
SVP and GM of Oncology
F - Tax
Common Stock
-490
$15.00
-7,350
1
$412.16M
2019-12-18
2019-12-20
HELSEL DAVE
SVP Global Operations and R&D
F - Tax
Common Stock
-736
$16.00
-11,776
1
$412.16M